sameAs
Routine use of oxygen in the treatment of myocardial infarction: systematic reviewInhaled magnesium sulfate in the treatment of acute asthmaSupplementary oxygen for nonhypoxemic patients: O2 much of a good thing?Frequency of venous thromboembolism in low to moderate risk long distance air travellers: the New Zealand Air Traveller's Thrombosis (NZATT) studyDose-response relation of inhaled fluticasone propionate in adolescents and adults with asthma: meta-analysisThe global burden of asthma: executive summary of the GINA Dissemination Committee reportRisk factors and immunity in a nationally representative population following the 2009 influenza A(H1N1) pandemicThree-month validation of a turbuhaler electronic monitoring device: implications for asthma clinical trial useEffectiveness of the 2009 seasonal influenza vaccine against pandemic influenza A(H1N1)2009 in healthcare workers in New Zealand, June-August 2009.Pandemic influenza A(H1N1)2009 in hospital healthcare workers in New Zealand.Effects of cannabis on pulmonary structure, function and symptoms.Worldwide trends in the prevalence of asthma symptoms: phase III of the International Study of Asthma and Allergies in Childhood (ISAAC)A multicentre feasibility study evaluating stress ulcer prophylaxis using hospital-based registry data.Association of asthma therapy and Churg-Strauss syndrome: an analysis of postmarketing surveillance data.Cumulative and single-dose design to assess the bronchodilator effects of beta2-agonists in individuals with asthma.A randomised controlled trial of topical Kanuka honey for the treatment of eczema.How much asthma is really attributable to atopy?Beta-agonist overuse and delay in obtaining medical review in high risk asthma: a secondary analysis of data from a randomised controlled trialBeta-agonists: what is the evidence that their use increases the risk of asthma morbidity and mortality?Asthma and the beta agonist debate.Proportional classifications of COPD phenotypes.Prevalence and etiology of asthma.Is allergen exposure the major primary cause of asthma?The rise and rise of asthma: a new paradigm for the new millennium?The role of paracetamol in the pathogenesis of asthma.Acetaminophen use and risk of asthma, rhinoconjunctivitis, and eczema in adolescents: International Study of Asthma and Allergies in Childhood Phase Three.Paracetamol in pregnancy and the risk of wheezing in offspring: a systematic review and meta-analysis.Withdrawal of fenoterol and the end of the New Zealand asthma mortality epidemic.Towards the optimal use of inhaled corticosteroid therapy in adult asthma.The contribution of histamine release to bronchoconstriction provoked by inhaled benzalkonium chloride in asthma.The influence of ipratropium bromide and sodium cromoglycate on benzalkonium chloride-induced bronchoconstriction in asthmaAerosolized magnesium sulfate for acute asthma: a systematic review.Epidemiology and costs of chronic obstructive pulmonary disease.Prescribed fenoterol and death from asthma in New Zealand, 1981-7: a further case-control studyReference ranges for exhaled nitric oxide derived from a random community survey of adults.The burden of asthma with specific reference to the United States.Case-control study of prescribed fenoterol and death from asthma in New Zealand, 1977-81Prescribed fenoterol and death from asthma in New Zealand, 1981-83: case-control study.A comparison of the extent and duration of hypokalaemia following three nebulized beta 2-adrenoceptor agonists.Fast-food consumption and body mass index in children and adolescents: an international cross-sectional study.
P50
Q22242035-01D8F22C-6FF1-45F5-886D-9D586B565D8FQ24202293-645BB981-A5F3-407C-A23B-F8BECB54BC6BQ24625685-82B43046-D1D5-47E3-8712-D3F7651E1FF7Q28166626-E8D664C7-C8FD-4D2F-8A87-BD5F171DFB48Q28345332-BCB2FA40-77A1-42FE-9557-226481B44C0BQ29614904-6ECA5099-0193-4AC5-9705-712D46D61804Q30395289-D106EE72-7AFA-456E-B465-3C6585FB8A34Q30397096-35EFF7FA-A5BD-447D-86D5-2EB11E9D10E3Q30398762-7612DE88-D181-412E-824C-671BCF89CED0Q30411463-F7056957-24BE-4F5D-ADEA-AF8246CCB03EQ30480738-AD2A61B0-9209-4286-91F2-38A98A5049D4Q30480797-6F446017-4E61-405C-BEBA-9BBBC3DA5431Q30845278-9A471C06-0D73-4221-8014-FA7EF89E6A56Q30955092-D1C7BBB0-2732-4F96-9CFA-741C50481A90Q31941411-6D434135-5489-4009-AFA4-07F8BD5CE7A3Q33576626-DE224D7E-0A03-418A-88FD-5ACC582BE4A8Q33634187-C162753D-C91E-4B8C-A3B4-1481D04F6003Q33698626-FBAE2367-2196-490C-A4A1-D13FB8B545B4Q33714802-D3E7BA26-E99D-4767-8FE9-D61D56A14344Q33821265-57CF6370-792E-40A2-BE40-8566A89FF809Q33824058-19DD02C3-E4C6-4C43-A002-42185FA2AF41Q33834980-84C3C8F8-F07D-4B08-8BD3-4DAD2A8FDA58Q33894492-0E9D893A-DF22-4054-A1FF-F6E52A602C4AQ33961816-1D70B95D-F01A-451B-9B20-04A8AC85ADDFQ34102363-401AA44C-ACE1-4DF7-B5D6-4423D3553699Q34131235-4140FDCA-813A-4E5D-89CC-FB5D5D3CBD8CQ34165951-99B962B2-9FCA-4517-93A4-0930FE9AFB2EQ34300131-14848293-84CC-4960-A4C8-2E4533FB1E5EQ34308533-B7BF60A2-8070-4CF7-A13A-D59720A25A58Q34417611-30482A2F-9ED5-4FC8-89A2-15969ABDC466Q34417954-8029FE16-54AB-4690-889B-2A2E3ED56AC4Q34432204-70992647-7322-40D2-8BA2-A0E285ACEC7DQ34563833-7B8C6855-4EE0-40C6-A573-34FCFA9E30F8Q34616592-6C044CDF-AA5E-42BC-8FA4-73714FD6DDF3Q34625434-FF3EB5C9-89BB-4DFD-A755-B261529106AFQ34627186-E2D19D03-D508-4AA5-9948-DA6DDBEB5A2EQ34647199-BFE0373B-1D00-498D-97F9-A9A7C9DCD0B8Q34667831-5F65A95D-D18D-46E2-BFDE-EAEB2C5036E5Q34667946-0D4F5002-4241-4F82-AFA3-926AB4A37CFCQ34692157-9E0B1DBF-396F-4DC9-A9FC-EE22CA188C52
P50
description
Medical researcher
@en
onderzoeker
@nl
name
Charles Richard William Beasley
@de
Charles Richard William Beasley
@fr
Charles Richard William Beasley
@pt
Richard Beasley
@ast
Richard Beasley
@en
Richard Beasley
@es
Richard Beasley
@nl
Richard Beasley
@sl
Richard Beasley
@sq
type
label
Charles Richard William Beasley
@de
Charles Richard William Beasley
@fr
Charles Richard William Beasley
@pt
Richard Beasley
@ast
Richard Beasley
@en
Richard Beasley
@es
Richard Beasley
@nl
Richard Beasley
@sl
Richard Beasley
@sq
altLabel
Charles Richard William Beasley
@en
Charles Richard William Beasley
@es
prefLabel
Charles Richard William Beasley
@de
Charles Richard William Beasley
@fr
Charles Richard William Beasley
@pt
Richard Beasley
@ast
Richard Beasley
@en
Richard Beasley
@es
Richard Beasley
@nl
Richard Beasley
@sl
Richard Beasley
@sq
P1006
P214
P2163
P244
P1006
P101
P1153
56666971400
P1960
eAfaL44AAAAJ
P21
P214
P2163
P244
P31
P496
0000-0003-0337-406X
P734
P7859
lccn-n92806258